FOLH1 and xerostomia: The ionizing radiation delivered to the salivary glands following PSMA-targeted radionuclide therapy damages the salivary glands, resulting in xerostomia, a debilitating condition, which severely decreases the quality of life and can even result in treatment discontinuation [6].